Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Get the latest updates from Investor Update directly as they happen.
Follow now 352 followers
Last updated 3 minutes ago
5 minutes ago
We are pleased to invite investors and analysts to participate in our...
about 19 hours ago
Rules out Alzheimer’s pathology in early stages to enhance diagnostic pathway efficiencyProvides...
1 day ago
Basel, 13 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
11 days ago
We are pleased to invite investors and analysts to participate in our...
11 days ago
Combination reduced the risk of disease progression or death by 46% and...
12 days ago
Basel, 1 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
14 days ago
Recently granted CE Mark, the novel test delivers improved sensitivity and accuracy...
21 days ago
Roche will publish its Sales for the 3rd Quarter of 2025 prior...
22 days ago
evERA met its co-primary endpoints; giredestrant plus everolimus demonstrated significant benefit in...
25 days ago
Lunsumio provides high and long-lasting response rates, with approximately two-thirds of patients...
26 days ago
89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe...
28 days ago
The Roche Investor Relations team would like to invite you to the...